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Molecular Prediction of Response to Chemotherapy
H Ho¨fler
Institute of Pathology, Technical University of Munich, Munich, Germany
This contribution is focused on the application of molecular diagnostic techniques
to enable individualization of therapy of malignant tumors. Molecular diagnostics
may lead to a therapeutic relevant molecular tumor classification and highlight
prognostic aspects, shed light onto tumor predisposition, etc. The highest and
clinically most relevant goal along this line, however, is the individualization of
tumor treatment, both, for the detection of new therapeutic targets/development of
specific drugs (Gleevec, Herceptin, etc.) and the prediction of response to
"classical" (poly-)chemotherapy. Currently, the routine detection of individual
therapeutic targets is restricted to few tumor entities but its numbers of application
is growing rapidly. The prediction of response to single ‘‘classical’’ chemother-
apeutic drugs or complex chemotherapeutic regimens in malignant tumors is still in
its infancy and would be of a major clinical relevance. One approach to
accomplish this high set goal is to study pretherapeutic tumor biopsies and perform
analysis on DNA-, RNA and protein level. Several technical aspects and
technologies including CGH-, LOH-, SNIP-analysis etc., RNA expression arrays,
quantitative RT-PCR technologies and proteomics approaches can be applied and
will be discussed on different examples of solid tumors in different locations.
Furthermore problems associated with these approaches will be stressed and
problem solving ideas will be presented. Among the problems discussed are
heterogeneity of tissue, genetic heterogeneity of tumors, study design, particularly
availability of representative patient cohorts and interpretation of results, including
statistical analysis.
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